Abstract
-Dear Editor, Paliperidone is an atypical antipsychotic drug formed by one of the active metabolites of risperidone, 9-hydroxirisperione.1 The drug demonstrates its effects by antagonizing central dopamine type-2 (D2) and serotonin type-2 (5HT2A) receptors. It could be used in acute stage and maintenance treatment of schizophrenia, and schizoaffective and bipolar disorders. In this letter, a case of male patient, who developed tardive dyskinesia due to paliperidone palmitate, is scrutinized. The objective of this letter is to call attention to the extrapyramidal side effects of stock paliperidone such as tardive dyskinesia, albeit rare.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
